BioSpace News Archive

Biogen Inc. (Nasdaq: BIIB) and Eisai Co., Ltd. (Tokyo, Japan) today announced additional details about the Phase 4 post-marketing confirmatory study, ENVISION, of ADUHELM ® (aducanumab-avwa) 100 mg/mL injection for intravenous use in early Alzheimer’s disease, including details of the study’s goal for diverse enrollment and primary endpoint.

Beyond Air, Inc. today announced that it will report financial results for its third fiscal quarter ended December 31, 2021 on Thursday, February 10, 2022.

PDS Biotechnology Corporation today announced preclinical data for its universal flu vaccine, which was shown to be effective against multiple strains of the influenza virus.

Alterity Therapeutics Limited (ASX: ATH, NASDAQ: ATHE) (“Alterity” or “the Company”), a biotechnology company dedicated to developing disease modifying treatments for neurodegenerative diseases, releases its Appendix 4C Quarterly Cash Flow Report and update on company activities for the quarter ending 31st December 2021 (Q2 FY22).

Nautilus Biotechnology, Inc. today announced it will report financial results for the fourth quarter and full year 2021 before market open on Thursday, February 24th , 2022.

ProKidney LP today announced the publication of the trial design of its Phase II clinical study of its novel Renal Autologous Cell Therapy (REACT®) in the American Journal of Nephrology.

Cocrystal Pharma, Inc. has selected two investigational novel antiviral drug candidates for further development as oral treatments for SARS-CoV-2, the virus that causes COVID-19.

InnovAge Holding Corp. (“InnovAge”) (Nasdaq: INNV) will release its 2022 fiscal second quarter financial results on Wednesday, February 9, 2022, after market close.

Brii Biosciences Limited today announced the appointment of Karen D. Neuendorff as Chief People Officer and Head of Human Resources (HR).

FX has completed the enrollment for their Investigational Device Exemption [IDE] study [G180100] on the Easytech Reversed® Stemless for reverse total shoulder arthroplasty becoming the first-and-only to do so.